» Articles » PMID: 30468374

Update on Pathogenesis of Hidradenitis Suppurativa

Overview
Date 2018 Nov 24
PMID 30468374
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The exact pathogenesis of hidradenitis suppurativa (HS) is still unproven. In the last few years numerous studies hypothesized that the disease is triggered by genetic and environmental factors. Follicular occlusion seems to be central to its development followed by follicular rupture, and immune responses finally leading to the development of clinical HS lesions. Data to date suggest that there is immune dysregulation in both the cutaneous and systemic immune system in patients with HS, but relative contributions from the innate and adaptive immune systems have not been fully elucidated. Furthermore, it can be further assumed that endocrine disorders related to follicular diseases can be implicated in the pathophysiologic pathways of HS. This review focuses on the key role of the immune system and endocrine disorders in the pathogenesis of HS.

Citing Articles

Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review.

Dec M, Arasiewicz H Postepy Dermatol Alergol. 2024; 41(1):9-19.

PMID: 38533374 PMC: 10962376. DOI: 10.5114/ada.2023.135617.


Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study.

Verde L, Cacciapuoti S, Caiazzo G, Megna M, Martora F, Cavaliere A J Transl Med. 2024; 22(1):149.

PMID: 38350939 PMC: 10863195. DOI: 10.1186/s12967-024-04853-0.


Item-specific patterns of the Skindex-17 in individuals with different levels of Hidradenitis Suppurativa severity: a network analysis study.

Raimondi G, Samela T, Fania L, Abeni D Front Public Health. 2023; 11:1284365.

PMID: 38026379 PMC: 10646184. DOI: 10.3389/fpubh.2023.1284365.


Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues.

Molinelli E, De Simoni E, Candelora M, Sapigni C, Brisigotti V, Rizzetto G Antibiotics (Basel). 2023; 12(6).

PMID: 37370297 PMC: 10295086. DOI: 10.3390/antibiotics12060978.


Topical finasteride: A potential therapeutic option for hidradenitis suppurativa.

Manfredini M, Alma A, Pongetti L, Sticchi A, Baschieri E, Farnetani F Dermatol Ther. 2022; 35(11):e15837.

PMID: 36114750 PMC: 9787594. DOI: 10.1111/dth.15837.